04/03/2024
4:02 PM | Domzalski David (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:04 PM | Harsch Mutya (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
11:15 PM | VYNE Therapeutics (Filer)
| Form EFFECT | |
03/01/2024
4:15 PM | VYNE Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/01/2024
4:16 PM | VYNE Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/29/2024
7:12 AM | VYNE Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
VYNE Therapeutics (Subject)
| Form SC 13G/A | |
|
02/02/2024
8:42 AM | Soleus Capital Master Fund, L.P. (Filed by)
VYNE Therapeutics (Subject)
| Form SC 13G/A | |
01/03/2024
4:17 PM | Domzalski David (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:20 PM | Harsch Mutya (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:21 PM | Stuart Iain (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:22 PM | VYNE Therapeutics (Issuer)
Zeronda Tyler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:07 PM | Borowski Christine (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:09 PM | BARBARI SHARON (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:10 PM | Basta Steven L (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:11 PM | Bruno Anthony D (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:13 PM | LEPORE PATRICK G (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:14 PM | Sandoval Elisabeth (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
7:15 AM | VYNE Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
4:11 PM | VYNE Therapeutics (Issuer)
Zeronda Tyler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
3:36 PM | VYNE Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/04/2023
3:30 PM | Domzalski David (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2023
11:15 PM | VYNE Therapeutics (Filer)
| Form EFFECT | |
11/16/2023
3:30 PM | VYNE Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/13/2023
3:41 PM | CITADEL ADVISORS LLC (Filed by)
VYNE Therapeutics (Subject)
| Form SC 13G | |
11/13/2023
3:30 PM | VYNE Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/13/2023
7:24 AM | AI Biotechnology LLC (Filed by)
VYNE Therapeutics (Subject)
| Form SC 13D | |
11/13/2023
7:30 AM | Access Industries Holdings LLC (Reporting)
ACCESS INDUSTRIES MANAGEMENT, LLC (Reporting)
AI Biotechnology LLC (Reporting)
Blavatnik Len (Reporting)
VYNE Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2023
6:57 AM | VYNE Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023
6:46 AM | VYNE Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:15 PM | Soleus Capital Master Fund, L.P. (Filed by)
VYNE Therapeutics (Subject)
| Form SC 13G | |
10/30/2023
6:30 AM | VYNE Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
3:26 PM | VYNE Therapeutics (Issuer)
Zeronda Tyler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
7:00 AM | VYNE Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2023
3:37 PM | VYNE Therapeutics (Issuer)
Zeronda Tyler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
3:30 PM | Domzalski David (Reporting)
VYNE Therapeutics (Issuer)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
3:32 PM | Harsch Mutya (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
3:34 PM | Stuart Iain (Reporting)
Stuart Iain (Reporting)
VYNE Therapeutics (Issuer)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | Domzalski David (Reporting)
VYNE Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2023
7:15 AM | VYNE Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
